Volta

Clinical impact of rapid molecular diagnostic tests in patients presenting with viral respiratory symptoms: A systematic literature review

Unknown authors · 2024
hash_id: 2804ea72343e6612f532751d848e1f72b2c0d594192396b1dbb76a28acd01cd1 · DOI: 10.1371/journal.pone.0303560

BACKGROUND: Molecular tests can detect lower concentrations of viral genetic material over a longer period of respiratory infection than antigen tests. Delays associated with central laboratory testing can result in hospital-acquired transmission, avoidable patient admission, and unnecessary use of antimicrobials, all which may lead to increased cost of patient management. The aim of this study was to summarize comparisons of clinical outcomes associated with rapid molecular diagnostic tests (RMDTs) versus other diagnostic tests for viral respiratory infections. METHODS: A systematic literature review (SLR) conducted in April 2023 identified studies evaluating clinical outcomes of molecular and antigen diagnostic tests for patients suspected of having respiratory viral infections. RESULTS: The SLR included 21 studies, of which seven and 14 compared RMDTs (conducted …

Reference & gravity metrics

Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP

Secondary-market trade history

No secondary-market trades recorded for this Volta yet.

References (0)

No outbound references recorded.

Cited by (2)

Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection secondary
Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An up… secondary